Accounts Payable, Current of Achilles Therapeutics plc from 31 Dec 2020 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Achilles Therapeutics plc quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2020 to 30 Jun 2024.
Achilles Therapeutics plc Accounts Payable, Current for the quarter ending 30 Jun 2024 was $2,865,000, a 58% decline year-over-year.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$2,865,000	-$4,021,000	-58%	30 Jun 2024	6-K	14 Aug 2024	2024	Q2
Q4 2023	$5,629,000	+$442,000	+8.5%	31 Dec 2023	6-K	14 Aug 2024	2024	Q2
Q2 2023	$6,886,000			30 Jun 2023	6-K	04 Aug 2023
Q4 2022	$5,187,000	+$1,465,000	+39%	31 Dec 2022	20-F	04 Apr 2024	2023	FY
Q4 2021	$3,722,000	-$2,592,000	-41%	31 Dec 2021	20-F	07 Mar 2023	2022	FY
Q4 2020	$6,314,000			31 Dec 2020	20-F	01 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.